Zoetis inc stock.

The average price point forecasted by analysts for Zoetis Inc (ZTS) is $222.04, which is $66.19 above the current market price. The public float for ZTS is 459.99M, and currently, short sellers hold a 0.65% ratio of that floaft. The average trading volume of ZTS on October 31, 2023 was 1.63M shares.PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the second quarter of 2023. The dividend will be paid on Thursday, June 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, April 21, 2023.April 30, 2020. Launched by leading animal health company Zoetis. Uniquely combines preventive care with best-in-class health insurance for dogs and cats. NEW YORK-- ( BUSINESS WIRE )-- Pumpkin Insurance Services , Inc. (“Pumpkin”), a new pet insurance agency and pet care company, announced today the launch of its new insurance and optional ...See the latest Zoetis Inc Class A stock price (ZTS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Currently, Zoetis Inc’s price-earnings ratio is 36.6. Zoetis Inc’s trailing 12-month revenue is $8.4 billion with a 27.2% profit margin. Year-over-year quarterly sales growth most recently was 7.4%. Analysts expect adjusted earnings to reach $5.418 per share for the current fiscal year.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

Zoetis Inc. announced that on February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at the Company, for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company. Mr.The stock price of Zoetis, an animal health company, has seen a 9% fall in a month, while it is down 6% in a week. The company reported upbeat Q4 results last month, with revenue of $2.0 billion ...

The largest individual shareholder of Apple, Inc. is Arthur D. Levinson, with over 1.1 million shares, as of late November 2014. Levinson is currently the non-executive Chairman of the Board of directors for Apple. He joined the Board in 20...Zoetis Inc. Class A Common Stock (ZTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Nov 11, 2022 · Zoetis has repurchased $545m of its stock in Q1-3, equivalent to 0.8% of its current market capitalization. Out of a $3.5bn share repurchase program authorized in December 2021, $3.0bn remained at ... Tracfone Wireless Inc has been a leading player in the telecommunications industry, offering innovative solutions and cutting-edge technology to its customers. With a focus on providing reliable and affordable wireless services, Tracfone ha...Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...

PARSIPPANY, N.J., March 13, 2023 -- ( BUSINESS WIRE )-- Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business ...

At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

For Fourth Quarter 2021, Zoetis Reports Revenue of $2.0 Billion, Growing 9%, and Net Income of $414 Million, or $0.87 per Diluted Share, on a Reported Basis Reports Adjusted Net Income of $474 Million, or Adjusted Diluted EPS of $1.00, for Fourth Quarter 2021 Delivers 9% Operational Growth in Revenue and 5% Operational Growth in Adjusted Net …See the latest Zoetis Inc Class A stock price (ZTS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.hace 6 días ... Zoetis Inc (ZTS) stock is trading at $177.45 as of 3:22 PM on Tuesday, Nov 28, a decline of -$1.34, or -0.75% from the previous closing price of ...Complete Zoetis Inc. stock information by Barron's. View real-time ZTS stock price and news, along with industry-best analysis.Zoetis. Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.

Nov 22, 2023 · The stock of Zoetis Inc (ZTS) has gone up by 3.52% for the week, with a 7.35% rise in the past month and a -3.00% drop in the past quarter. The volatility ratio for the week is 2.00%, and the volatility levels for the past 30 days are 2.50% for ZTS. The simple moving average […] Zoetis Inc. (4ZTS.BIT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis Inc. | Borsa Italiana: 4ZTS | Borsa ItalianaZoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First ...The estimated Net Worth of Gregory Norden is at least $9.81 Million dollars as of 17 June 2023. Mr. Norden owns over 14,851 units of Zoetis Inc stock worth over $8,091,578 and over the last 10 years he sold ZTS stock worth over $1,360,615. In addition, he makes $355,000 as Independent Director at Zoetis Inc.ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation.Latest news about Zoetis Inc. Transcript : Zoetis Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01:00 PM. Nov. 28. CI. Zoetis Insider Sold Shares Worth $2,298,856, According to a Recent SEC Filing. Nov. 21. MT. Zoetis Insider Sold Shares Worth $163,796, According to a Recent SEC Filing.

With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

ZTS Sales vs. its Competitors Q3 2023. Comparing the current results to its competitors, Zoetis Inc reported Revenue increase in the 3 quarter 2023 by 7.44 % year on year. The revenue growth was below Zoetis Inc 's competitors' average revenue growth of 7.44 %. Select the Relationship:ZTS : 180.21 (+0.48%) 3 Pharma Stocks With Potential to Outperform Pfizer Inc. (PFE) in October stocknews.com - Thu Oct 5, 2:14PM CDT. Pfizer (PFE) is grappling with financial difficulties and declining performance. Yet, with growing pharmaceutical demand and industry advancements, robust pharma stocks Zoetis (ZTS), Horizon Therapeutics...Zoetis Declares Fourth Quarter 2023 Dividend October 12, 2023. Zoetis Named a 100 Best Company for Working Parents by Seramount October 10, 2023. Zoetis to Host Webcast and Conference Call on Third Quarter 2023 Financial Results September 27, 2023. Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for …Dec 3, 2023 · Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats ... Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Vanessa Broadhurst ZTS stock SEC Form 4 insiders trading. Vanessa has made over 3 trades of the Zoetis Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Vanessa exercised 1,592 units of ZTS stock worth $272,670 on 10 February 2023.. The largest trade Vanessa's ever made was exercising 2,557 units of …As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers ...

Zoetis may alter or terminate the terms of the FP Guarantee at any time and for any reason. GBF-00659. Beef news & updates. August 3, 2022. Press Release Zoetis Recieves Expanded Labels For Beef Implant Products. August 29, 2022. Press Release Zoetis Continues Support of Folds of Honor Mission With Donation.

The stock price of Zoetis, an animal health company, has seen a 9% fall in a month, while it is down 6% in a week. The company reported upbeat Q4 results last month, with revenue of $2.0 billion ...

The estimated Net Worth of Catherine A. Knupp is at least $17 Million dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,683,611 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President and President - Research …18 feb 2022 ... ... Zoetis Inc. Zoetis (ZTS) stock forecast: will the healthcare stock rebound? – Photo: Shutterstock. US-based animal healthcare company Zoetis ...Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.Zoetis. Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.Company’s entry into reference lab space adds to its increasing capabilities in diagnostics, a category of the animal health industry with approximately 10% compound annual revenue growth over the last three years 1. PARSIPPANY, N.J. & MUKILTEO, Wash.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced the completion of …At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Solensia ™ to control the pain of osteoarthritis (OA) in cats, helping improve their mobility, comfort and overall well-being. 1 As a once-monthly injection administered in the veterinary clinic, …The estimated Net Worth of Robert W Scully is at least $6.5 Million dollars as of 19 February 2021. Mr. Scully owns over 7,590 units of Zoetis Inc stock worth over $1,359,597 and over the last 13 years he sold ZTS stock worth over $4,789,296. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Zoetis. Market Cap. Today's Change. Current Price. $180.21. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s ...US98978V1035. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.13 abr 2023 ... Zoetis Inc. (ZTS) develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States ...

The company reported revenue of $2.0 billion for the third quarter of 2022, an increase of 1% compared with the third quarter of 2021. Net income for the third quarter of 2022 was $529 million, or $1.13 per diluted share, a decrease of 4% and 3%, respectively, on a reported basis. On an operational 1 basis, revenue for the third quarter of 2022 ...ZTS Sales vs. its Competitors Q3 2023. Comparing the current results to its competitors, Zoetis Inc reported Revenue increase in the 3 quarter 2023 by 7.44 % year on year. The revenue growth was below Zoetis Inc 's competitors' average revenue growth of 7.44 %. Select the Relationship:The Zoetis stock price fell by -0.667% on the last day (Wednesday, 29th Nov 2023) from $176.97 to $175.79. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.61% from a day low at $175.24 to a day high of $178.06. The price has risen in 6 of the last 10 days and is up by 1.82% over the past 2 weeks.Analyst Forecast. According to 6 analysts, the average rating for ZTS stock is "Strong Buy." The 12-month stock price forecast is $223.0, which is an increase of 24.27% from the latest price.Instagram:https://instagram. sofi dividendsfree trial grocery delivery63snextera energy investors The estimated Net Worth of Catherine A. Knupp is at least $17 Million dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,610,292 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President und President - Research …Nov 29, 2023 · Zoetis (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis | Nyse: ZTS | Nyse what is the current 6 month treasury bill ratebest dental insurence Get real-time Zoetis (ZTS) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing.Zoetis Inc (ZTS) stock is up 1.56% while the S&P 500 is lower by -0.73% as of 3:06 PM on Monday, Dec 4. ZTS is up $2.79 from the previous closing price of … docusign stock forecast Dec 4, 2023 · Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ... Nov 28, 2023 · On Monday, Zoetis Inc [NYSE:ZTS] saw its stock fall -0.79% to $178.79. On the same session, the stock had its day’s lowest price of $178.47, but rose to a high of $180.79. Over the last five days, the stock has gained 2.28%. Zoetis Inc shares have risen nearly 22.00% since the year began. Zoetis Inc (ZTS) stock has gained 0.48% while the S&P 500 is down -0.74% as of 3:11 PM on Thursday, Nov 9. ZTS is higher by $0.82 from the previous closing price of $170.90 on volume of 2,430,877 shares. Over the past year the S&P 500 has gained 13.65% while ZTS is higher by 26.07%. ZTS earned $4.92 a per share in the over the last 12 months ...